Cumulative Anticholinergic Exposure Is Associated with Poor Memory and Executive Function in Older Men

Abstract

OBJECTIVES To examine the longitudinal relationship between cumulative exposure to anticholinergic medications and memory and executive function in older men. DESIGN Prospective cohort study. SETTING A Department of Veterans Affairs primary care clinic. PARTICIPANTS Five hundred forty-four community-dwelling men aged 65 and older with diagnosed hypertension. MEASUREMENTS The outcomes were measured using the Hopkins Verbal Recall Test (HVRT) for short-term memory and the instrumental activity of daily living (IADL) scale for executive function at baseline and during follow-up. Anticholinergic medication use was ascertained using participants' primary care visit records and quantified as total anticholinergic burden using a clinician-rated anti-cholinergic score. RESULTS Cumulative exposure to anticholinergic medications over the preceding 12 months was associated with poorer performance on the HVRT and IADLs. On average, a 1-unit increase in the total anticholinergic burden per 3 months was associated with a 0.32-point (95% confidence interval (CI) = 0.05–0.58) and 0.10-point (95% CI = 0.04–0.17) decrease in the HVRT and IADLs, respectively, independent of other potential risk factors for cognitive impairment, including age, education, cognitive and physical function, comorbidities, and severity of hypertension. The association was attenuated but remained statistically significant with memory (0.29, 95% CI = 0.01–0.56) and executive function (0.08, 95% CI = 0.02–0.15) after further adjustment for concomitant non-anticholinergic medications. CONCLUSION Cumulative anticholinergic exposure across multiple medications over 1 year may negatively affect verbal memory and executive function in older men. Prescription of drugs with anticholinergic effects in older persons deserves continued attention to avoid deleterious adverse effects.

Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women

“…Han et al demonstrated that anticholinergic exposure with multiple medications has a cumulative effect on cognitive function. [25] This cumulative effect was confirmed in a recent longitudinal study of over 13,000 elderly adults. [26] Ancelin et al found that elderly adults taking various anticholinergics had multiple areas of cognitive dysfunction: reaction time, attention, memory, recall, visuospatial construction, and language tasks.…”

An overview of the LASER-AD study: A longitudinal epidemiological study of people with Alzheimer's disease

“…There is increasing evidence that anticholinergic medications may adversely affect cognitive function (Han et al, 2008;Tune 2001). These are used in a variety of conditions, for example psychiatric conditions, cardiac disease and bladder illnesses and people with dementia take these medications because of multiple illness comorbidities (Schubert et al, 2006).…”

Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients

“…There have been longitudinal studies which have shown that anticholinergic medications are associated with function decline [Han et al 2008;Hilmer et al 2009].…”